Scenic Biotech
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $38M
Investors
- 6
About Scenic Biotech
V.V. specializes in pioneering therapeutic solutions for genetic disorders.Scenic Biotech specializes in the development of a pioneering therapeutic approach known as modifier therapy, aimed at treating genetic disorders linked to neuro- and metabolic diseases. Their core offerings focus on identifying and leveraging modifier genes, which act as "hidden disease protection factors" to counteract the effects of primary disease-causing mutations. This innovative methodology allows for the rebalancing of health by modulating alternative genomic functions rather than directly targeting the original mutations. The company employs its proprietary Cell-Seq platform to discover these modifier genes, facilitating the creation of a diverse pipeline of novel therapeutics.Scenic Biotech's revenue structure is primarily driven by strategic partnerships and collaborations with established pharmaceutical companies. The firm’s partnerships facilitate the advancement of its therapeutics pipeline, with a focus on modifier therapy, which is a unique class of treatment that addresses complex genetic disorders. While specific pricing plans for individual products or services are not disclosed, the company’s revenue generation is supported by the commercial success of its pipeline candidates once they reach market readiness. The company is also looking to expand its market presence across Europe and North America, targeting areas with significant unmet medical needs, although specific new product release dates and further market expansion timelines have not been disclosed.
Who invested in Scenic Biotech
6 investors across 2 rounds
See all investors in Scenic Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Scenic Biotech
Who invested in Scenic Biotech?
Scenic Biotech has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Scenic Biotech raised?
Scenic Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Scenic Biotech last raise money?
Scenic Biotech's most recent round on record is a Series A, in Mar 2022.
What does Scenic Biotech do?
Scenic Biotech is a biotechnology company.
Where is Scenic Biotech headquartered?
Scenic Biotech is headquartered in Amsterdam, Netherlands.
Which VCs invest in companies like Scenic Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Scenic Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Scenic Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.